ANN ARBOR STAGE IB HODGKIN LYMPHOMA
Clinical trials for ANN ARBOR STAGE IB HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANN ARBOR STAGE IB HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for ANN ARBOR STAGE IB HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smart scans guide tailored therapy for hodgkin lymphoma patients
Disease control OngoingThis study tests a personalized approach for people with early-stage Hodgkin lymphoma. Doctors use PET scans to decide if standard chemotherapy alone is enough or if adding immunotherapy drugs can improve results. The goal is to boost survival while limiting unnecessary treatment…
Matched conditions: ANN ARBOR STAGE IB HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
New hope for seniors with hodgkin lymphoma: Chemo-Free combo shows promise
Disease control OngoingThis study tests a combination of two drugs, nivolumab and brentuximab vedotin, in people aged 60 or older (or younger people who cannot take standard chemotherapy) with untreated Hodgkin lymphoma. The goal is to see how well this drug pair works in shrinking or eliminating the c…
Matched conditions: ANN ARBOR STAGE IB HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC